Effects of NANOG Expression on Proliferation and Cell Cycle of Acute Lymphoblastic Leukemia Cells

孟凡静,李莉,曹江,吕超,周俊,程海,陈伟,陈翀,徐开林
DOI: https://doi.org/10.3760/cma.j.issn.1673-419x.2014.02.003
2014-01-01
Abstract:Objective To explore the expression of NANOG gene in acute lymphoblastic leukemia (ALL) cell lines and the effect of down-regulation of NANOG on the proliferation and cell cycle of ALL cells.Methods Three kinds of ALL cell line MOLT-4,CCRF-HSB2 and Jurkat were chosen as study object.The expression of NANOG was detected by reverse transcription-polymerase chain reaction (RTPCR) and Western blot in MOLT-4,CCRF-HSB2 and Jurkat cells.The lentiviral vector (pLB-shNANOG-1 and pLB-shNANOG-2) carrying NANOG specific shRNA were constructed.After infection of MOLT-4 cells with the lentivirus constructs,green fluorescent protein positive cells were harvested by flow cytometry as interference group.With empty plasmid (pLB-sh control) infected MOLT-4 cells and normal cells were used as wild-type group and control group.The efficiency of RNA interference was detected by real-time quantitative PCR and Western blot.Cell proliferation was evaluated using CCK-8 cell counting kit.Cell cycle was analyzed by flow cytometry.The expression of p53-related gene was detected by real-time quantitative PCR.Results The virus titers were (1.83-3.12)×108 IU/mL.Each interfering sequence cloud stably down-regulate the expression of NANOG.Analysis of cell proliferation indicated that the MOLT-4 cells expressing NANOG shRNA grew significantly slower than wild-type cells and control cells,and this difference became more obvious after 72 hours (P<0.001).Cell cycle analysis indicated that the percentage of S-phase cells in wild-type or control group cells was obviously increased when compared to MOLT-4 cells expressing NANOG shRNAs (P<0.01).The percentage of MOLT-4 cells expressing NANOG shRNAs in the G0/G1-phase was higher than in wild-type cells and control cells (P<0.001),while the percentage of cells in the G2/M-phase was not statistical different among these cells (P>0.05).The expression of gene TP53 and CDKN1A were increased in groups of shNANOG-1 and shNANOG-2 than that of groups of control and wild-type (P<0.05).But the expression of gene MDM2 and CCND1 was decreased (P<0.05).Conclusions NANOG is expressed in some human ALL cell lines.Down-regulation of NANOG could inhibit cell proliferation and arrest in the cell cycle of G0/G1 phase through a MDM2-TP53 CDKN1A pathway in leukemic cells.
What problem does this paper attempt to address?